Substantial BSX Losses? Don't Miss Your Chance to Lead the Class Action by May 4

SAN DIEGO – March 18, 2026 – Robbins Geller Rudman & Dowd LLP has announced a deadline for investors to seek appointment as lead plaintiff in a class action lawsuit against Boston Scientific Corporation (NYSE: BSX). The legal action is on behalf of individuals who purchased or acquired Boston Scientific common stock during the period from July 23, 2025, through February 3, 2026, inclusive of both dates. Affected investors have until May 4, 2026, to file their application to serve as lead plaintiff in the case, which is captioned *Troike v.*

Based on Ranked Stocks' quantitative analysis, Boston Scientific (BSX) currently holds an RS Score of 51.96, placing it in the 10.20th percentile within its country and the 7.14th percentile in its sector. The stock demonstrates strength in Profitability, with a score of 80.40. However, it shows weaker performance in other key areas, including Valuation (46.92), Growth (14.10), Momentum (8.38), and EPS Revisions (70.00). Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.